Cannabis abuse linked to psychiatric symptoms but not thyroid or cardiovascular changes

In a study of 40 cannabis-dependent patients vs 40 healthy controls, cannabis abuse was associated with significant psychiatric symptoms but did not significantly alter thyroid hormones or cardiovascular parameters, likely due to tolerance development.

Muzaffar, Anum et al.·Frontiers in psychiatry·2021·Preliminary EvidenceProspective Cohort
RTHC-03371Prospective CohortPreliminary Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Prospective Cohort
Evidence
Preliminary Evidence
Sample
N=40

What This Study Found

Cannabis-dependent patients showed highly significant differences (P < 0.001) in positive, negative, and general psychopathology scores on the PANSS compared to controls. Among patients, 47.5% had schizophrenia, 20% schizoaffective symptoms, 10% manic symptoms, and 22.5% both manic and psychotic symptoms. Thyroid hormones (TSH, T3, T4) and cardiovascular parameters did not differ significantly between groups.

Key Numbers

40 patients vs 40 controls; 47.5% schizophrenia; PANSS scores P < 0.001; thyroid and cardiovascular parameters non-significant

How They Did This

Prospective multicenter study comparing 40 cannabis-dependent patients with psychotic symptoms (selected by DSM-IV criteria and urine testing) to 40 healthy controls. Thyroid hormones measured by immunoassay, psychiatric symptoms by PANSS, and cardiovascular parameters assessed.

Why This Research Matters

The dissociation between significant psychiatric effects and non-significant thyroid/cardiovascular changes in chronic cannabis users suggests tolerance may develop to some physiological effects while psychiatric vulnerability persists or worsens.

The Bigger Picture

The finding that the body adapts (develops tolerance) to cannabis's thyroid and cardiovascular effects while psychiatric effects remain prominent suggests different biological systems respond differently to chronic exposure.

What This Study Doesn't Tell Us

Small sample. Cross-sectional comparison cannot determine whether cannabis caused psychiatric symptoms. All patients already had psychotic symptoms at enrollment. No dose-response analysis.

Questions This Raises

  • ?Would thyroid effects appear in non-tolerant users?
  • ?Does tolerance to cardiovascular effects provide false reassurance while psychiatric risk persists?
  • ?Are the psychiatric symptoms truly cannabis-caused or pre-existing?

Trust & Context

Key Stat:
Significant psychiatric symptoms (P < 0.001) but non-significant thyroid/cardiovascular changes
Evidence Grade:
Small multicenter study with validated psychiatric assessments, but cannot establish causation and patients were pre-selected for psychotic symptoms.
Study Age:
Published in 2021.
Original Title:
Clinical Investigation on the Impact of Cannabis Abuse on Thyroid Hormones and Associated Psychiatric Manifestations in the Male Population.
Published In:
Frontiers in psychiatry, 12, 730388 (2021)
Database ID:
RTHC-03371

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-ControlFollows or compares groups over time
This study
Cross-Sectional / Observational
Case Report / Animal Study

Enrolls participants and follows them forward in time.

What do these levels mean? →

Frequently Asked Questions

Does cannabis affect thyroid hormones?

Not in this study. Despite chronic cannabis dependence, thyroid hormone levels (TSH, T3, T4) did not significantly differ between cannabis-dependent patients and healthy controls, which researchers attributed to tolerance.

What psychiatric symptoms were found?

Among 40 cannabis-dependent patients, 47.5% had schizophrenia, 20% schizoaffective symptoms, and others had manic or combined manic-psychotic symptoms, all with significantly elevated PANSS scores.

Read More on RethinkTHC

Cite This Study

RTHC-03371·https://rethinkthc.com/research/RTHC-03371

APA

Muzaffar, Anum; Ullah, Sami; Subhan, Fazal; Nazar, Zahid; Hussain, Syed Mehdi; Khuda, Fazli; Khan, Abuzar; Khusro, Ameer; Sahibzada, Muhammad Umar Khayam; Albogami, Sarah; El-Shehawi, Ahmed M; Emran, Talha Bin; Javed, Binish; Ali, Javed. (2021). Clinical Investigation on the Impact of Cannabis Abuse on Thyroid Hormones and Associated Psychiatric Manifestations in the Male Population.. Frontiers in psychiatry, 12, 730388. https://doi.org/10.3389/fpsyt.2021.730388

MLA

Muzaffar, Anum, et al. "Clinical Investigation on the Impact of Cannabis Abuse on Thyroid Hormones and Associated Psychiatric Manifestations in the Male Population.." Frontiers in psychiatry, 2021. https://doi.org/10.3389/fpsyt.2021.730388

RethinkTHC

RethinkTHC Research Database. "Clinical Investigation on the Impact of Cannabis Abuse on Th..." RTHC-03371. Retrieved from https://rethinkthc.com/research/muzaffar-2021-clinical-investigation-on-the

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.